1. Home
  2. TREX vs CPRX Comparison

TREX vs CPRX Comparison

Compare TREX & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trex Company Inc.

TREX

Trex Company Inc.

HOLD

Current Price

$38.97

Market Cap

3.9B

Sector

N/A

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$31.26

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TREX
CPRX
Founded
1996
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.4B
IPO Year
1998
2006

Fundamental Metrics

Financial Performance
Metric
TREX
CPRX
Price
$38.97
$31.26
Analyst Decision
Buy
Strong Buy
Analyst Count
17
1
Target Price
$49.53
$35.00
AVG Volume (30 Days)
1.9M
3.2M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.24
EPS
0.58
0.50
Revenue
$1,174,267,000.00
$119,072,803.00
Revenue This Year
$5.09
$9.20
Revenue Next Year
$6.24
$10.51
P/E Ratio
$66.77
$62.57
Revenue Growth
1.98
16.39
52 Week Low
$29.77
$19.05
52 Week High
$68.78
$32.56

Technical Indicators

Market Signals
Indicator
TREX
CPRX
Relative Strength Index (RSI) 49.89 72.98
Support Level $35.25 $22.24
Resistance Level $44.76 $31.29
Average True Range (ATR) 2.00 0.31
MACD -0.06 -0.13
Stochastic Oscillator 36.30 95.59

Price Performance

Historical Comparison
TREX
CPRX

About TREX Trex Company Inc.

Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: